Atlas Venture

Atlas Venture is one of the most established and well-respected biotech venture firms in the world, headquartered in Cambridge, Massachusetts, with a multi-decade track record of company creation in therapeutics. The directory entry has limited disclosed data, but Atlas’s actual pattern is well-known: deep biotech and therapeutics investing, frequently as a co-founder and seed investor in companies it builds itself, with the ability to follow a portfolio company through multiple growth rounds; check sizes range from a few million at company-formation to tens of millions at Series A and B. Best fit: scientific founders coming out of MIT, Harvard, the Broad, or other top labs with a deep therapeutic insight, often paired with an Atlas EIR or co-founder; founders building category-defining biotech, not platform plays. Entry path is the Atlas Venture website (the partners’ bios indicate their therapeutic-area focus) and warm intros through Cambridge’s biotech community, the Broad, Harvard, and MIT tech transfer offices. Not a fit for digital health, healthcare IT, medical devices, life sciences tools, or any non-therapeutics company. AI exposure is via specific portfolio companies (e.g., generative-bio plays) rather than thematic; do not pitch Atlas as an AI-first investor.